Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kotaro Ohnishi

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Biochemical and Biophysical Research Communications|July 15, 2014
Epigenetic regulation leading to induced pluripotency drives cancer development in vivoKotaro Ohnishi, Katsunori Semi, Yasuhiro Yamada
International Journal of Cancer|November 28, 2012
Cellular reprogramming and cancer developmentKatsunori Semi, Yutaka Matsuda, Kotaro Ohnishi, et al.
Cell|February 18, 2014
Premature termination of reprogramming in vivo leads to cancer development through altered epigenetic regulationKotaro Ohnishi, Katsunori Semi, Takuya Yamamoto, et al.
Nature Communications|August 20, 2021
DMRT1-mediated reprogramming drives development of cancer resembling human germ cell tumors with features of totipotencyJumpei Taguchi, Hirofumi Shibata, Mio Kabata, et al.
Cell Reports|February 24, 2021
Inhibition of FGF10-ERK signal activation suppresses intraductal papillary neoplasm of the bile duct and its associated carcinomasHiroyuki Tomita, Kaori Tanaka, Akihiro Hirata, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Biochemical and Biophysical Research Communications|July 15, 2014
Epigenetic regulation leading to induced pluripotency drives cancer development in vivoKotaro Ohnishi, Katsunori Semi, Yasuhiro Yamada
International Journal of Cancer|November 28, 2012
Cellular reprogramming and cancer developmentKatsunori Semi, Yutaka Matsuda, Kotaro Ohnishi, et al.
Cell|February 18, 2014
Premature termination of reprogramming in vivo leads to cancer development through altered epigenetic regulationKotaro Ohnishi, Katsunori Semi, Takuya Yamamoto, et al.
Nature Communications|August 20, 2021
DMRT1-mediated reprogramming drives development of cancer resembling human germ cell tumors with features of totipotencyJumpei Taguchi, Hirofumi Shibata, Mio Kabata, et al.
Cell Reports|February 24, 2021
Inhibition of FGF10-ERK signal activation suppresses intraductal papillary neoplasm of the bile duct and its associated carcinomasHiroyuki Tomita, Kaori Tanaka, Akihiro Hirata, et al.
Pageof 1